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Abstract
In the United States over 40 million women have
experienced or have undergone menopause (Scharbo-Dehaan,
1996) . With a decrease in estrogen levels associated with
menopause, women encounter a number of increased health
risks, such as osteoporosis, heart disease, cancer, and
Alzheimer's disease (Howell & Brodman-Grimm, 1999). The
event of menopause varies for all women. The typical
experience will include mood swings and sleep disturbance,
skin alterations, urogenital atrophy, and or hot flashes
and night sweats (Mayer & Linscott, 1995). Hormone
replacement therapy (HRT) has been shown to improve the
negative effects of menopause. With all the benefits of
HRT, there are also controversies related to the risk such
as endometrial and breast cancer (Scharbo-Dehaan, 1996).
Morever, only 20% of postmenopausal women receive HRT, and
many of those women are noncompliant (Cumming & Cumming,
1998a). Therefore, this study examined the use or nonuse
of HRT in rural southern women. Parse's Human Becoming
Theory was used as the conceptual framework for this
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study. A researcher-designed questionnaire was the
instrument used. The research questions were designed to
assess the use and nonuse of HRT and the reasons for use
or nonuse. The setting consisted of a beauty shop and a
church in northeast Mississippi. Data analysis was done by
descriptive statistics. The findings revealed that an
almost equal amount of women were using HRT compared to
those not using HRT. The major reason for use was health
care provider instructed the women to use HRT and the
reason for nonuse was that they did not think they needed
the medication. Nurse practitioners should recognize the
issue of nonuse of HRT and educate these women on the
effects of menopause and associated long-term
complications. Recommendations include using a more
diverse sample to include a larger cultural population.
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Chapter I
The Research Problem
Menopause has been defined as "a time in a woman's
life when menstruation ceases to exist--along with her
capability to bear children" (Howell & Brodman-Grimm,
1999, p. 3). It occurs at an average age of 51 years, can
transpire anytime between the ages of 45 and 55, and has
been reported to occur before the age of 40 years in 8% of
women (Howell & Brodman-Grimm, 1999). In the United States
over 40 million women have experienced or have undergone
menopause (Scharbo-Dehaan, 1996).
Hormone replacement therapy (HRT) has been shown to
improve the negative effects of menopause (Scharbo-Dehaan,
1996) . Some of these effects are physical and emotional
changes, hot flashes, night sweats, a decrease in libido,
vaginal dryness, and depression. With a decrease in
estrogen levels due to menopause, women encounter a number
of increased health risks, such as osteoporosis, heart
disease, cancer, and Alzheimer's disease, which may be
diminished by HRT (Howell & Brodman-Grimm, 1999).
1
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Only 20% of postmenopausal women receive HRT, and
many of those women are noncompliant (Cumming & Cumming,
1998a) . Newton et al. (1997) published a study in which
1,082 women were asked why they chose not to take or
stopped taking HRT. The reasons most cited were that
hormones were not needed and that menopause was a
naturally occurring event. Side effects, physician's
advice, fear of cancer, and not wanting to have any
bleeding were also mentioned. A greater understanding of
women's beliefs, culture, and decision-making process is
needed related to the use or nonuse of HRT (Sarrel, 1999).
Therefore, the focus of this study was to examine the use
or nonuse of HRT in rural southern menopausal women.
Establishment of the Problem
Life expectancy for American women is 84 years of
age. Three and a half million women will reach midlife in
this decade. Due to the increasing number of women going
through menopause, more research and understanding need to
be done on the use of HRT by menopausal women (ScharboDehaan, 1996).
Women experiencing menopause have the potential for
major health problems as a result of the decrease in
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estrogen. These difficulties include osteoporosis, heart
disease, colo-rectal cancer, and Alzheimer's disease
(Howell & Brodman-Grimm, 1999). Twenty-five million
Americans have osteoporosis with 80% of those being women.
Furthermore, $10 million is being spent on complications
from osteoporosis yearly. Hip fractures will occur in
250,000 Americans this year. Of those, 20% will die and
another 60% will have to be institutionalized (Grisanti,
Willington, & Marrale, 1998).
Caucasian menopausal women lose between 2% and 5% of
bone mass per year. Forty to 50% of women over 55 years of
age suffer at least one fracture in their lifetime
(Grisanti et al . , 1998). Of women ages 45 and older, 1.3
million fractures will occur due to osteoarthritis,
consequently nearly 20% of hip fracture clients do not
survive for more than a year (Howell & Brodman-Grimm,
1999).
The use of estrogen therapy has been shown to be the
most helpful practice to reduce the incidence and
progression of osteoporosis (Smith & Hughes, 1998). In the
Postmenopausal Estrogen Progestin Intervention Trial
(Grisanti et al . , 1998), 875 postmenopausal women were
studied who utilized estrogen therapy. Bone mass at the
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spine increased from 3.5 to 5% and hip bone mass by 1.7%
with bone mineral density increasing in 95% of the
participants in the first 3 years of estrogen therapy.
Estrogen therapy initiated in early menopause has shown to
have the greatest impact on increased bone density.
Moore and Noonman (1996) found that "cardiovascular
disease is the leading cause of death in women in the
United States, accounting for approximately 50% of all
deaths in women older than 50" (p. 17). Low high-density
lipoprotein and high low-density lipoprotein levels are
risk factors of coronary artery disease and stroke.
Estrogen replacement therapy has shown to account for a
40% to 50% reduction in coronary artery disease and a 31%
decrease in the incidence of a stroke (Mayeaux & Johnson,
1996) . Additionally, estrogen therapy has been shown to
increase high-density lipoprotein and decrease low-density
lipoprotein, therefore, reducing the risk of
cardiovascular disease by one half (Moore & Noonman,
1996).
The second most often diagnosed cancer and the number
three cause of cancer death in American women is colo
rectal cancer. It is projected that 7% of Americans will
be diagnosed with this disease this year. The risk of
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colo-rectal cancer increases with age. Recent studies have
shown that women using HRT have a 20% lower risk of
developing this disease than those who do not (Howell &
Brodman-Grimm, 1999).
Alzheimer's disease affects 4 million Americans
today. Women are affected three times more than men with
the majority of those affected over 65 years of age.
Estrogen levels have been shown to be related to memory
loss (Howell & Brodman-Grimm, 1999). Data in the Baltimore
Longitudinal Study of Aging found that 54% of women using
HRT had reduction in the development of Alzheimer's
disease with a higher dose and a longer duration of
estrogen use reducing the risk (Grissanti et al., 1998).
When the body no longer manufactures enough hormones
to manifest menstruation, menopause transpires. The event
of menopause varies for all women. The typical experience
will include mood swings and sleep disturbances, skin
alterations, urogenital atrophy, and or hot flashes and
night sweats (Mayer & Linscott, 1995). For some women,
these symptoms are undesirable factors that can interfere
with quality of life and activities of daily living. In
addition, fluctuating hormones have shown to alternate a
woman's mood. Depression is specifically relevant to

decreased circulating estrogen. Women in menopausal
clinics have reported increased mood swings during
menopause (Cumming & Cumming, 1998a).
Skin changes occur with increased age due to a
decrease in skin collagen. Estrogen therapy has been shown
to decrease the appearance of wrinkles by increasing
dermal and total skin thickness (Mayeaux & Johnson, 1996).
Vaginal irritation, pruritus, vaginitis, cystitis,
urinary incontinence, and dyspareunia are common problems
related to a decrease in estrogen. Vaginal lubrication
decreases with the vaginal epithelium becoming atrophied.
The anterior vagina loses tone related to factors
associated with menopause, such as aging, decreased muscle
stimulating, and the effects of child bearing. HRT has
been shown to relieve urogenital atrophy symptoms (Moore &
Noonman, 1996).
One of the most common complaints of menopausal women
are hot flashes. They are the body's reaction to decreased
estrogen levels. Hot flashes occur in 75% of women
experiencing menopause. Hot flashes consist of recurrent
transient periods of (a) flushing, (b) sweating, (c)
feeling of being hot often followed by chills, (d)
palpitations, and (e) anxiety. HRT is the most utilized
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solution to alleviate the symptoms of hot flashes (Shaw,
1997) .
With all the benefits of HRT, there are also
controversies related to the risk, such as endometrial and
breast cancer. The use of estrogen without progestin added
(unopposed estrogen) has been linked to the risk of
endometrial cancer by 1% to 2% times in the first 3 years
of use and a 10 times greater risk with longer
utilization. With today's HRT that combines estrogen with
12 days of progestin therapy a month, the risk no longer
exist (Scharbo-Dehaan, 1996) .
Approximately 43,500 women died of breast cancer in
the United States in 1998. Breast cancer is most common
cancer in women and the second leading cause of death
(Cummings & Cummings, 1998a). More than 50 studies have
been done regarding the use of estrogen therapy related to
breast cancer. The results have been controversial in
relation to the dose selection and the duration of the
therapy. The use of estrogen therapy for less than 10
years is not related to cancer, but with a longer duration
of use a 30% to 50% increase incidence has been found
(Grisanti et al., 1998). Another study published by the
Collaborative Group on Hormonal Factors and Breast Cancer
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involving more than 160,000 women worldwide over a 25-year
period indicated an increase in the diagnosis of breast
cancer for women receiving HRT for over 5 years. Those who
criticized the study pointed out that women who used HRT
generally also have a mammography yearly; therefore, the
breast cancer is found earlier than in women who may not
have the cancer detected until a lump is felt. The type or
dosage of estrogen was not found to influence the risk of
breast cancer. The risk of cancer from taking HRT vanishes
after 5 years from stopping the medication (Cumming &
Cumming, 1998b). Regardless of the risk, the death of
women from heart disease is 10 times greater than the
death rate from breast cancer (Howell & Brodman-Grimm,
1999) .
Perceptions related to HRT are related to rumor than
the facts. Most women are informed about the benefits of
reducing the symptoms of menopause but have inaccurate or
little knowledge of the long-term benefits related to a
decrease in heart disease and osteoporosis. Many women
focus on the risk of cancer which may be over exaggerated
and do not realize that the benefits of HRT outweigh this
risk (Sarrel, 1999).
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SigiiiXj._C_ajlC_e to Nursi rig
The significance of this study as related to nursing
includes practice, research, theory, and education. A
discussion of rural southern women in relation to these
aspects of nursing follows:
Practice. This study will enhance the nurse
practitioner's knowledge of the use of HRT in rural
southern women. When women are experiencing symptoms of
menopause, they typically turn to the health care provider
for assistance. The nurse practitioner often assumes the
role of counselor, educator, and partner in helping to
individualize the management of HRT. The nurse
practitioner must also take into consideration the women's
health care beliefs and concerns related to menopause and
the use of HRT. This study will broaden the practitioners'
information on the reasons behind the use or nonuse of HRT
in the rural southern woman.
Research. Although extensive research exists on HRT,
none was found on the use in rural southern women. The
literature that exists often has conflicting and confusing
data related to the benefit of symptom relief and the risk
of cancer. The literature also involves the long-term
benefits associated with cardiovascular disease and
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osteoporosis. Conclusions that are made today are
challenged many times by new research. Nurse practitioners
must be attentive to new developments. This study will
enlighten research related to the use of HRT in a rural
southern community. All practice is supported by research;
therefore, the findings in this study can be utilized in
the primary care setting.
Theory^ Parse's Human Becoming Theory is pertinent as
it relates to the effects of menopause and the use of HRT.
The goal in the methodology is the quality of life as
defined by the person and the family. What is described as
quality of life for one person may be different for
another individual (Parse, 1992). To Parse (1995), quality
of life is human's living moment to moment as the changing
patterns of shifting perspectives weave the fabric of life
as it connects with the universe. The nurse practitioner
who practices the human becoming theory must center on the
significance of the client's hopes and dreams as described
by them. The health care provider has the opportunity to
co-participate with the client in the "whatness" of life
(Daly, Mitchell, & Jonas-Simpson, 1996). When advising a
client concerning HRT, the nurse practitioner needs to be
in tune with the beliefs of the client.
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Education. Research in nursing is the backbone of
nursing education. What nurse practitioners learn from
research is generated into material that guides what is
taught in the primary care setting to the clients. The
primary care provider must be equipped with knowledge
related to the culture in which he or she is practicing.
In this study, data were obtained from rural southern
women. These data can educate the practitioner in beliefs
and concerns related to this population of women. Other
research has shown that only 20% of postmenopausal women
receive HRT. Many of those women are noncompliant. Health
care providers need to advise women on the risk and
benefits and individualize therapy for each person.
Ongoing counseling and education may enhance adherence and
lessen fears and doubts concerning HRT (Cumming & Cumming,
1998a). Nurse practitioners should use the opportunity
associated with education related to HRT to emphasize the
promotion of other health behaviors. Yearly mammograms and
breast examination to include compliance with self-breast
exam, annual pelvic examination that includes a
Papanicolaou (Pap) test are a few of the educational
aspects of a nurse practitioner's role (Moore & Noonman,
1996).
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Theoretical Frampwnrk
Parse's (1995) Theory of Human Becoming was used to
guide this research study. The Human Becoming Theory
consists of three themes: meaning, rhythmicity, and
contransendence. Each theme includes three principles,
referred to as assumptions. Nine assumptions make up the
major concepts and definitions of the Human Becoming
Theory (Parse, 1995).
The first principle, meaning, consists of the
concepts of imaging, valuing, and languaging. Individuals
gain meaning of what is real for them through experiences
and choices that they make daily. People use language at
every moment, from speaking to body language when they are
silent. Valuing is what the individual cherishes, meaning
changes as life is experienced (Parse, 1995).
The second principle, rhythmicity, consists of the
concepts of revealing-concealing, enabling-limiting, and
connecting-separating. Humans live in a paradox of
opposites, each unable to exist without the other.
Individuals reveal and are thereby concealing. Humans are
enabled and limited in the same breath by choices. Each
choice has limitations and opportunities. In the universe
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humans connect and separate in moving apart and coming
together all at one time in the rhythm of the universe
(Parse, 1995) .
The third principle, contransendence, has three
concepts consisting of powering, originating, and
transforming. People are unique human beings, wanting to
be different but at the same time striving to be the same.
Paths that are chosen shed a different light on how one
processes the familiar (Parse, 1995).
Parse's (1995) Theory of Human Becoming is important
in relation to the experience a woman encounters regarding
menopause. The central phenomenon is the relationships
among the human, the universe, and health. Health is
defined as the quality of life experienced. The individual
defines quality of life. The human, himself or herself,
describes what is meaningful in life. The quality of one's
becoming represents how the person represents his or her
priorities (Parse, 1995). Research studies have shown that
the utilization of HRT in relation to menopause increases
quality of life. The assessment of quality of life has
become frequently used when measuring the outcome of
treatment (Limouzin-Lamothe, Mairon, Joyce, & Le Gal,
1994).
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Many women who realize that menopause is on the
horizon feel the need to reevaluate their entire lives.
Attitude toward the inevitable makes a great difference in
how menopause will be experienced. Women look back on
their accomplishments and realize that a part of lives has
come to an end. Looking forward to the future is the best
way to minimize the difficulties that may later develop
(Howell & Brodman-Grimm, 1999). Humans freely choose ways
to react to changes in situations. While illuminating, the
woman will look at who she was prior to menopause, who she
is presently, and who she will be in the future (Parse,
1995) .
The goal of the nurse's practice, as described by
Parse, is to participate in cocreating quality of life.
Life is full of changes such as menopause. Some women will
look at this as a positive aspect while others will find
this to be a challenging time in their life. The health
care provider must focus on what this situation means to
each individual. Quality of life can be enhanced when
health care providers put into practice Parse's Human
Becoming Theory (Parse, 1995).
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Assumptions
For the purpose of this study, the following
assumptions were made:
1. Menopause symptoms impact women's quality of life.
2. Humans freely choose ways to react to changes in
situations.
3. Health practices can be identified.
4. Environmental factors can impact health practices.

Menopause has been shown to have a significant
present and future impact on women. Each woman reacts
differently to menopause. Women's quality of life can be
affected by the number and degree of the symptoms. Many
studies have focused on the utilization of HRT for the
relief of symptoms and the long-term benefits related to
osteoporosis and heart disease (Mayer & Linscott, 1995).
Much research has been reported on estimates of HRT
use. Despite the potential for protection against
osteoporosis and cardiovascular disease, noncompliance has
been documented in the United States and elsewhere
(Salamone, Pressman, Seeley, & Cauley, 1996). Data to date
on the use of HRT have been derived from specific
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communities or occupational groups and may not be
generalizable (Brett

Madans , 1997). The existing
Sc.

research studies have looked at women based on race,
ethnicity, or culture when examining the practice of HRT.
Rural southern women's HRT practices have not been
identified. For the purpose of this study, the use of HRT
in southern rural menopausal women will be explored.
Research Questions
This study was guided by three questions:
1. What is the prevalence of hormone replacement
therapy in rural southern menopausal women?
2 . What reasons do rural southern menopausal women
cite for using hormone replacement therapy?
3 . What reasons do rural southern menopausal women
cite for not using hormone replacement therapy?
Befiniiion of Xerms
For the purpose of this study, the following terms
were identified:
(HRT): Theoretical: the
use of exogenous synthetic estrogen and progestin in
combination. Operat.i ona.1: the ingestion of estrogen (ERT)
or HRT by rural menopausal women.

Chapter II
Review of the Literature
A review of the literature revealed many studies on
the incidence of menopause and the use of hormone
replacement therapy (HRT). Many studies explored the risk
and benefits associated with the utilization of the
medication. Other studies revealed women's beliefs and
decisions related to HRT. Studies were conducted in a
variety of geographic areas. However, little research was
found which addressed the utilization of HRT in the rural
South. Therefore, the focus of this selected review of the
literature was studies related to the risk, benefits, and
utilization of HRT.
In a study by Utian and Boggs (1999) , perceptions of
menopause were examined. The purpose of the study was to
determine the effects of menopause on women. The research
question that guided the study was as follows: Howe does
menopause affect women?
The researchers used a descriptive longitudinal
design with a convenience sample of 752 American women
18
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between the ages of 50 and 65 years in 1993, 1997, and
1998 . Since the results of the 1993 and 1997 surveys were
previously reported, this review includes only the results
from the 1998 telephone survey. The survey used both openand closed-ended questions (Utian & Boggs, 1999).
The women were asked how old they were when they
experienced their last natural period. In women ages 50 to
65, the average age at last period was 49 years. When
asked if they had a surgical removal of the uterus
(hysterectomy) , 45% of the women ages 50 to 65 responded
that they had a hysterectomy. The women were asked if
specific areas of their lives had changed since
experiencing menopause. More than half stated they had not
noted changes in work, home life, sexual relations,
friendships, or ability to focus on hobbies. Approximately
50% reported no change in their present activities of
daily living although 26% experienced deterioration.
Twenty-four percent described their health as better since
experiencing menopause. The majority (51-s) showed no
change in sexual relations. In regard to quality of life,
those women who experienced a hysterectomy expressed a
better quality of life than those who did not. Seventy
percent of those women who had the hysterectomy were
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taking HRT, and 41% of the women who had natural menopause
were taking HRT. Fifty-one percent of the women had
modified their diet. Fourteen percent stated they thought
there was more information available to them than the
previous generation. Sixteen percent of the women reported
that they would talk to the next generation along longterm effects of menopause. A majority of the women (60%)
did not feel their mother prepared them for menopause
(Utian & Boggs, 1999) .
In summary, the majority of women did not find
menopause to be a negative aspect of their life. They felt
they had a better understanding of menopause in respect to
earlier generations but were not educated by their
mothers. A majority were using HRT but did talk about HRT
use to others. Many did not discuss the long-term effects
but wanted to acknowledge this concern with the future
generation (Utian & Boggs, 1999) . This study is germane to
the current researcher's endeavor in that menopausal women
have a better understanding than previous generations and
with more education and communication the long-term
complications of menopause can be examined and rectified
with the use of HRT.

21

Menopause is regarded by many women as neither good
nor

bad but as a naturally occurring phenomenon. Studies

have shown that women have optimistic or impartial
reactions to the event of menopause. Daly et al. (1993)
uncovered a different reflection of the menopausal
experience. The purpose of the research was to evaluate
the quality of life of menopausal women. The research
question was as follows: Do menopausal symptoms impact
quality of life?
Menopausal symptoms were defined as mild and severe.
Daly et al. (1993) defined mild menopausal symptoms as (a)
having occasional hot flashes once or twice daily with
occasional night sweats, (b) concentration, confidence,
and coping skills decreasing with feelings of tiredness
increasing, or (c) painful dry vagina. Severe symptoms
were defined as (a) severe hot flashes hourly with nightly
sweating causing the need to change nightgown, (b) lack of
concentration, confidence, and coping skills causing
problems at home, or (c) complete disinterest in sex.
The design used was a cross-sectional nonexperimental
method. The researchers used a convenience sample and
recruited 63 women between the ages of 45 and 60 years
from three clinics. Data were collected from the women
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either before or after a medical appointment. Two methods
were used to determine quality of life. The first method
was referred to as the rating scale for which the subject
picked a point on a scale that expressed the quality of
life identified with the particular health state that was
in question. The second method, known as the time tradeoff
method, asked the subjects to determine the tradeoff
between life lived with reduced health or less years lived
with normal health. The women listened to a description of
symptoms of mild menopause, then rated quality of life as
if they were experiencing these symptoms from a scale of 0
to 10 with 0 as normal health and 10 being dead. Subjects
then listened to a description of the severe symptoms and
rated quality of life. Finally, subjects again heard the
mild symptoms and were asked to determine if they would
choose between 5 years with these symptoms or a lesser
number of years with a normal lij_e and the same action
with severe symptoms. The last part of the questionnaire
included some general questions pertaining to the
subject's own history of menopausal symptoms and their use
or nonuse of HRT (Daly et al. , 1993) .
To analyze the data the researchers divided the
sample (N = 63) into three subgroups. The first group

23

(nonusers) were women who had not used HRT (n = 21). Of
these 21, 16 had mild symptoms, 4 had severe symptoms, and
one had no symptoms. The second subgroup (users-mild)
consisted of women who had taken hormone replacement and
experienced mild symptoms (n = 17) . The last group (userssevere) was women with severe symptoms who had taken HRT
(n = 25) (Daly et al., 1993).
Daly et al. (1993) determined the mean age of the
sample was 52 years. The women who experienced menopausal
symptoms stated that the description read to them
coincided with their own symptoms. In the ratings scale
the subjects' scores indicated a low quality of life
associated with menopausal symptoms. Subjects who had used
HRT indicated they would be willing to trade off years for
a better quality of life. For those women who suffered
severe symptoms, quality of life improved after taking
HRT. Daly et al. (1993) stated "the time trade off
approach may be a truer reflection of the perceived
reduction in quality of life associated with menopausal
symptoms" (p. 837) .
Daly et al. (1993) used a table to signify qualifyof-life values related to HRT and severity of symptoms. A
95% confidence level was used. The table indicated that
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quality-of-1ife ratings improved, especially with women
who had experienced severe symptoms. The mean increase was
0.56 for the utility value. For the women with milder
symptoms, the mean increase was 0.18. Two out of 42
reported a decrease in quality of life, but they had been
on the treatment for less than 6 months.
In summary, a greater number of women experienced
positive quality-of-life results from the utilization of
HRT. Women felt that quality of life is diminished by the
onset of menopausal symptoms (Daly et al. , 1993). The
study was germane to the current researcher's endeavors in
that menopausal symptoms have been found to decrease the
quality of life for menopausal women. Also, HRT can
increase quality of life or lessen those symptoms of
menopause.
Menopausal symptoms can be treated by two different
methods, either symptomatically or by using HRT. LimouzinLamothe, Mairon, Joyce, and Le Gal (1994) sought to
determine if HRT influenced quality of life of menopausal
women. The purpose of the research was to establish the
effects of HRT on quality of life. The researcher
introduced the need to evaluate how HRT impacted quality
of life of menopausal women. The researchers' question was
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as follows: Does hormone replacement therapy impact
quality of life of menopausal women?
Limouzin-Lamothe et al . (1994) defined quality of
life as a variety of psychological and physiological
traits and boundaries that portray a person's capacity to
endure and enjoy life. HRT was described as either
transdermal estradiol in association with chormadinone
acetate or the ingestion of veralipride.
The design used was descriptive longitudinal. The
researchers used convenience sampling to enroll 101
practicing physicians with 499 women who were assigned to
two groups in the randomized, open trial study. The women
had experienced menopause either naturally or surgically
and had amenorrhea ^ 3 months but ^ 3 years. Additional
criteria for inclusion were symptoms of hot f1ashes and
i^j_gh.t sweats. None of the subjects had been treated with
estrogen or HRT in the past. Four-hundred seventy - nine of
the 499 subjects completed the study. Two-hundred forty
received the HRT, and 239 received the symptomatic
treatment (Limouzin-Lamothe et al. , 1994) .
Data were collected from the women on four separate
occasions. The four sessions included (a) before treatment
to verify criteria to participate in the study, physical
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examination, and mammography, (b) 3 weeks after the first
visit to start treatment for the subjects participating in
the study, (c) 3 months after treatment started for
monitoring, and (d) 6 months after treatment for the final
assessment. The subjects were either given a continuous
dosage of Estraderm TTS 50 plus Chlormadinone acetate 10
mg daily for the first 12 days of every month or
veralipride 100 mg daily for the first 20 days of each
month. The dosage of Estraderm was individualized as the
physician saw necessary (Limouzin-Lamothe et al. , 1994).
The women completed questionnaires after visits two,
three, and four and mailed them to the coordinating
center. The questionnaire, the Menopausal Global Health
Status Indicator, incorporated 112 questions. Ten symptoms
were rated on a 4-point scale from 10 as no menopausal
symptoms to 40 having all 10 menopausal symptoms. The t
test was utilized for the between-group comparison.
Quality of life before the treatment and after the
treatment was analyzed by covariance analysis. Chi square
was used to assess for global efficacy and global
tolerance. Clinical efficacy was analyzed with the 5%
level, and the 1% level was used to assess quality of life
(Limouzin-Lamothe et al., 1994).
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Limouzin-Lamothe et ai. (1994) determined at the end
of the treatment, HRT (p < .0001) was favored. An overall
increase in satisfaction (p < .001) also was noted on the
Sexual Behavior Questionnaire as the global score was
higher with the use of HRT (p = .04) on the inclusion
visit. Quality of life improved at 3 months for both
groups with a further increase in 6 months. Global
differences were higher after 6 months with the use of
HRT. Hot flash symptoms decreased in 81% of the women
receiving HRT and 44% in the women receiving the
symptomatic treatment.
Limouzin-Lamothe et al . (1994) stated that "the
results of this multicenter, open randomized trial showed
that HRT improves the quality of life of menopausal women
and also showed the superiority of Estraderm TTS over
symptomatic treatment in regard to clinical efficacy

(p-

621) . The researchers determined that quality of life
improved after 6 months regardless of the method used
although enhancement of quality of life was greater with
HRT. The reviewed study is germane to the current
researcher's endeavor in that HRT has been found to
increase quality of life for menopausal women. Menopause
affects women's lives in varying degrees and its utility
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may differ from woman to woman. The current study was
conducted in an effort to determine the use or nonuse of
HRT.
Researchers have asserted that menopausal symptoms
affect quality of life. Wiklund, Karlberg, and Mattsson
(1993) hypothesized that HRT had considerable effect on
quality of life of menopausal women. The researchers
introduced the study problem as having to evaluate how HRT
impacted quality of life of menopausal women. The research
question was as follows: Does estradiol therapy affect
quality of life of menopausal women? Quality of life was
defined as the ability to function in activities of daily
living with feelings of general well-being. Estradiol
therapy was defined as estrogen therapy gi\en in
transdermal form.
The design used was a randomized clinical trial
method. The researchers used a convenience sampling design
and recruited 242 women between the ages of 45 and 65
years from 15 clinics. Data were collected from the women
who volunteered during a visit to the gynecologist or
answered an advertisement in the local newspaper. The
women had amenorrhea for at least 6 months. Women were
excluded who were menopausal due to surgery, had current

life threatening diseases, certain medical conditions, or
had a history of psychological disorders (Wiklund et al. ,
1993) .
The women were randomly and blindly placed in two
groups. The women (N = 223) were divided as n = 112
receiving transdermal estradiol therapy of 50 mg/24 hours
or n = 111 receiving the placebo patches twice weekly. The
study was continued over a 12-week period. Women were
assessed at baseline and at 6 and 12 weeks. The
Psychological General Well-Being Index was utilized as the
questionnaire. The stringent alpha level of 0.01 was
chosen (Wiklund et al., 1993).
Five women receiving the placebo and an equal number
of women receiving estradiol experienced symptoms of
menopause related to the therapy. There was no difference
in the women in the aspect of breakthrough bleeding.
Wiklund et al . (1993), using the Nottingham Health
Profile, indicated that sleep and emotions improved with
both groups of women, but the women using estradiol
therapy had a greater increase. Those women using
estradiol therapy had a better score concerning anxiety,
well-being, vitality, and self-control than those women on
the placebo. Women using estradiol also had significant
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improvements on the Women's Health Questionnaire. Sexual
enhancement improved as measured by the McCoy Sex Scale
among those women using the transdermal estradiol patch (p
< .0001).
Wiklund et al . (1993) found that "the effect of
transdermal estradiol therapy was considerably more
pronounced, as assessed both objectively and subjectively,
compared with that of placebo" (p. 829). Health problems
identified as menopausal symptoms that interfere with
daily activities were modified with the use of transdermal
estradiol therapy. Despite the contraindications of HRT,
the utilization of these medications has the potential to
nullify those menopausal symptoms that decrease a woman s
quality of life. This study was germane to the current
researcher's endeavor in that HRT has been found to
increase the quality of life of menopausal women, yet
little is known about the utility and outcomes of HRT
among southern rural menopausal women.
Newton et al. (1997) sought to explain the decision
making process of women related to the use of HRT. The
purpose of the study was to investigate reasons why women
initiate, discontinue, or do not use HRT. The following
research questions guided this study:
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1 . What were the reasons for taking HRT?
2 . What were the reasons for discontinuing HRT?
Newton et al. (1997) defined HRT as estrogen
replacement therapy with or without progestins. Reasons
for taking or not taking HRT were defined as (a)
menopausal symptoms, (b) osteoporosis prevention, (c)
physician advice, (d) fear of cancer, (e) not wanting
menstrual periods or bleeding, (f) hormones not being
needed, and (g) belief that menopause was a natural event.
The design used was a cross-sectional nonexperimental
method. The researchers used a convenience sampling design
a.nd recruited 1,083 postmenopausal women 50 years of age
or older obtained from a medical care facility in a
western state. A telephone survey was conducted. The
participants were asked questions regarding demographics,
menopausal status, HRT practices, reasons for use or
nonuse of HRT, changes in the utilization of HRT, and if
HRT had been stopped (Newton et al. , 1997).
Data analysis was conducted using chi-square tests.
Age-adjusted proportions were used to determine the
differences in the reasons for initiating or not
initiating HRT or for changing or stopping HRT. Logistic
regression was then conducted to compare the likelihood of
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being a current or past user of HRT to never having used
HRT (Newton et al., 1997).
Participants were categorized as follows: (a) current
users (42.5%), (b) past users (20.9%), and (c) never
having taken HRT (36.6%). Top reasons given by current
users and past users for initiating HRT were menopauserelated symptoms (48.7%), prevention of osteoporosis
(32.6%) and recommended by physician (29.6%). One hundred
forty-five (31.5%) of the current users reported a need to
alter the use of HRT due to no improvement of menopausal
symptoms (29.0%) , physician advice (13.1%) , or side
effects (26.9%). Of the past users, 53.8% stopped on their
own, and 46.2% stopped with the advice of a physician.
Reasons cited for discontinuation ranged from 39% because
of or feared side effects, 15.2-6 because of withdrawal
bleeding, 22.9% upon a physician's advice, and 15.4% due
to the fear of cancer. Among women who had never started
HRT, 33.1% had considered utilization, 46.6-s had discussed
usage with a health care provider, and 5.0% had not gotten
the prescription filled. Reasons cited for never starting
HRT were thinking hormones were not needed (49.9%) and
.dering menopause a natural event (17.9%). Age did not
consic

play a role in reasons for never using HRT, but age was
cited as reason for stopping HRT (Newton et al. , 1997).
Newton et al . (1997) concluded that menopausal
symptoms, osteoporosis, and a physician's advice were
associated with the use of HRT. The benefit related to
cardiovasculature was not noted by the women. Therefore,
the researchers recommended more education and counseling
by health care providers to emphasize the risks and
benefits of HRT in order for clients to have a better
understanding before decisions are made. The study was
germane to the current research as it illuminated the
variances in knowledge and risk factors associated with
HRT.
Salamone et al. (1996) sought to understand the low
utilization of HRT in older menopausal women and to
determine the reason for use or nonuse. The research
question was as follows: Why do older menopausal women not
take HRT? Menopausal women was defined as women ages 65
and older. HRT was defined as oral estrogen.
The design used was descriptive longitudinal. The
researchers used convenience sampling including 7,667
post-menopausal women ages 65 and older who had
participated in a previous estrogen questionnaire from
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1986 to 1988 in four clinics located in the northern
United States. This particular survey took place on the
third visit to clinic between 1990 and 1992. The
questionnaire included demographics, medical history,
family and personal fracture history, activity, and
alcohol consumption. Three closed-ended questions related
to estrogen therapy also were listed on the questionnaire
(Salamone et al. , 1996).
When answering questions requiring multiple
responses, dichotomous variables (yes or no) were created
to compare percentages of positive responses. For singleresponse questions, frequency distributions were used.
Data were analyzed using percentage distributions and chisquare tests and the Student t tests (Salamone et al. ,
1996) .
Findings revealed that 17.2% of the sample was
composed of current estrogen users. Primary reasons for
initiating estrogen therapy among current users were
hysterectomy (43.5%), menopausal symptoms (37.3%),
physician recommendation (38.7%), and prevention of
osteoporosis (33.6%). Heart disease prevention was a
reason for 1.5% of estrogen users. Among previous users
(27.2%) of the sample, the same reasons were given for the
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initiation of estrogen therapy. Reasons for discontinuing
estrogen were 30.5% from thinking they did not need it,
16.4% did not understand the side effects, and 15.3%
thought the medication might be harmful. For those women
who had never taken estrogen (55.6% of the sample), their
reasons included believing the medication might be harmful
(38.1%) and thinking they need it (29.5%) . Physicians had
counseled only 4.1% of these nonusers on the need for
estrogen replacement therapy (Salamone et al. , 1996).
In summary, Salamone et al. (1996) found that women
who were currently on estrogen replacement therapy were
more aware of the long-term benefits of estrogen therapy
with the past users and nonusers being afraid of the risk.
Continual education of not only the clients but also
health care providers is necessary to accomplish the goal
of long-term benefits that are needed for menopausal
women. The study was germane to the current research as it
demonstrated that all menopausal women regardless of age
need education on the risk and benefits of HRT.
Information related to the use and education variables is
scarce regarding southern rural menopausal women.
Postmenopausal estrogen deficiency increases
cardiovascular risk, and heart disease is the leading
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cause of death among postmenopausal women. Menopausal
women who are treated with HRT have a lower rate of
coronary heart disease (CHD). HRT has been shown to alter
women's lipid profiles but effects on cardiac structure
and function are still uncertain. Therefore, the purpose
of Kamali, Muller, Lang, and Clapp's (2000) study was to
evaluate cardiovascular function in perimenopausal women
before and during the first 21 weeks of combined HRT. The
hypothesis for the study was combined HRT alters both
central and peripheral cardiovascular aspects during the
first months of therapy.
Kamali et al . (2000) designed an experimental cohort
study using convenience sampling and recruited 6 women
between the ages of 50 and 55 from a newspaper
solicitation. Initial heart rate, systemic blood pressure,
left ventricular volumes, venous capacitance and
compliance, and hormonal levels were obtained. These
measurements were obtained for 3 weeks prior to initiation
Q£ HRT

Afer 3 weeks the women were given estradiol 2 mg

on days 1-21 and 1 mg on days 23-28 of the cycle.
Additional measurements were obtained during the time when
the women were only receiving 2 mg's of estradiol on weeks
1, 5, 9, and 21.
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Data were analyzed by repeated-measures analysis of
variance to determine if any changes occurred. Comparison
tests to examine within-group differences were conducted
post hoc. Tukey's exact t tests were used for pairwise
comparisons, and the Dunnett test was performed for the
multiple comparison values against the control values. The
Friedman repeated-measures analysis was used if the
distribution was not normal. Linear regression, with an
alpha of < .05 and all data presented as mean plus or
minus standard error of the mean, was used to determine
significant relationships between the cardiovascular
aspects and hormonal parameters (Kamali et al. , 2000).
Findings revealed that no changes occurred in the 3
weeks prior to initiation of HRT. Heart rate, blood
pressure, venous capacitance, or venous compliance did not
alter during the 21-week treatment. By the ninth week enddiastolic volume had risen 18%, and stroke volume had
risen by 19%. Because of these increases cardiac output
rose 18% in the ninth week, and 57% of that was during the
first 5 weeks of therapy. Total peripheral resistance fell
from 1293 ± 64 kg/m to 1097

±

53 dyne (cm. sec -5) (p <

.01) during 9 weeks of therapy. Serum estradiol levels
miIr-h (n <
rose three times as mucn ip

001). Correlations were
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significant between estradiol concentration and enddiastolic volume (r2 = 0.49), stroke volume (r2 = 0.63),
and mean arterial pressure (r2 = 0.87) after 9 weeks of
HRT. Correlations between estradiol concentration and
cardiac output (r2 = 0.14) and total peripheral resistance
(r2 = -0.23) were significant (Kamali et al. , 2000).
Kamali et al . (2000) determined that structural and
functional changes begin in the first month of HRT and
continue to increase in the second month. This study is
germane to the current research study in that HRT has been
shown to enhance the cardiovascular system in menopausal
women, yet it remains unknown if southern rural menopausal
women know or use this information when deciding to
institute HRT.
Following menopause rapid bone loss is accelerated
from a deficiency in estrogen from ovarian failure. Among
women ages 50 and older, 20% have osteoporosis in both the
hip and spine. Estrogen therapy protects women from bone
loss and fracture. HRT is the single best prevention of
osteoporosis, but questions still remain related to tne
effects of HRT on bone mineral density (BMD) . Bush et al.
(1996) examined the effects of HRT on BMD in the hip and
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spine of postmenopausal women. How does HRT affect BMD was
the researchers' question.
The design used was an experimental cross-sequential
method. The researchers used convenience sampling to
recruit 875 women between the ages of 45 and 64 years from
seven clinical centers. The women were randomly divided
into 5 groups. The groups were as follows with a 28-day
medication regimen: (a) placebo, (b) conjugated equine
estrogen 0.625 mg daily, (c) estrogen 0.625 mg daily with
medroxyprogesterone acetate 10 mg daily for days 1-12,
(d)estrogen 0.625 mg daily with medroxyprogesterone 2.5 mg
daily, and (e) estrogen 0.625 mg daily with micronized
progesterone 200 mg for days 1-12. The women returned to
the clinic three times the first year and twice yearly for
the next 2 years. Menopausal symptoms, vaginal bleeding,
medication used and adherence to the assigned medications,
side effects, and fractures were assessed at each visit. A
questionnaire including demographics, lifestyle, and prior
use of HRT was given at each visit. Lifestyle
characteristics included alcohol consumption, exercise,
smoking, and calcium intake (Bush et al., 1996).

Statistical analysis included observational measures
to calculate the percentile change from baseline of each
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woman. In the first stage unadjusted mean BMD was
determined for all the women. Unadjusted percentile
changes in the mean BMD at the hip and spine were examined
graphically at each visit for all women. In the second
stage, both average and annual percentile changes were
analyzed in a repeated measures model using PROC MIXED to
test pairwise differences between treatment regimes for
all women. With multiple comparisons, significance levels
were not adjusted. In the third stage, which included only
those women who adhered to the entire length of the
treatment, unadjusted mean percentile changes from
baseline to the 36-month visit were assessed. This change
was compared with factors, such as age, ethnicity,
smoking, alcohol consumption, calcium intake, exercise,
body size, and prior HRT use. The factors were added to a
general linear model with the treatment regimen, clinic
center, hysterectomy status, and baseline BMD to determine
if the factors accounted for any variation m the change
of BMD from baseline (Bush et al., 1996)
Bush et al. (1996) found that at the end of the study
78% of the women were using the combination treatment, 74%
of the women were using the placebo, and 56% of the women

using only estrogen were adherent to the therapy. For all
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participants, women given any type of therapy had a mean
total increase in BMD in their spine of 3.5 to 5.0% as
compared to the women receiving the placebo who lost BMD
with a mean total decrease of 1.8% at the end of the 3
years. Women who were taking the combined hormone therapy
had an increase of 5.0% as compared to the women who took
other active treatments (3.8%). Women using the placebo
lost 1.7% BMD compared to the active treatment women who
increased their hip BMD by 1.7%. For those women who
adhered to entire length of the treatment, women using an
active treatment had an increase in spinal BMD of 5.1% and
a hip BMD increase of 2.3%. Those women taking the placebo
had a decrease in spinal BMD of 2.8% and hip BMD decrease
of 2.2%.
In summary. Bush et al. (1996) determined that
regardless of factors that may influence bone loss, HRT
increased BMD in the spine and hip over a 3-year period.
Women who took only the placebo were noted to lose BMD in
both the hip and spine. This research is germane to the
current research in that HRT has been shown to be of
benefit for all postmenopausal women. However, little is
known about the utility of HRT in the population of rural
southern menopausal women examined in the current study.
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Many studies have been conducted regarding the use of
HRT and breast cancer. The Collaborative Group on Hormonal
Factors in Breast Cancer (1997) brought together many
studies on this subject. The purpose of the meta-analysis
was to evaluate data related to the risk of breast cancer
and the use of HRT. The researchers introduced the problem
as the need to evaluate if there was a higher risk of
breast cancer when using HRT. Does the utilization of HRT
increase the risk of breast cancer was the researchers
question.
The Collaborative Group on Hormonal Factors in Breast
Cancer (1997) used a cohort design to compare the use of
HRT against the risk of breast cancer. A convenience
sample from 51 prior studies, including 161,116 women from
21 countries were utilized. Data collected in the studies
from 1976 to 1992 included demographics, reproductive
history, use of HRT, age of cessation of menstruation and
reason for cessation, gynecological surgery, height,
weight, and age at menarche. The women were placed in two
groups, women with breast cancer (n - 52,705) and women
without breast cancer (n = 108,411). women also were
classified into groups according to whether or not their
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ovaries were likely to be producing hormones around the
time the breast cancer was diagnosed.
Mantel-Haenszel stratification techniques were
conducted to analyze the risk of breast cancer in relation
to HRT use. The stratum-specific quantities calculated
were the standard observed minus expected number of women
with breast cancer and their variances and covariances.
These values yielded both statistical descriptions and
statistical probabilities. Risk estimates also were
obtained by the one-step method, along with standard
errors and confidence intervals (Collaborative Group on
Hormonal Factors in Breast Cancer, 1997).
The Collaborative Group on Hormonal Factors in Breast
Cancer (1997) found that 41% of the women were
premenopausal, 3% were perimenopausal, and 42% were
postmenopausal. Of the postmenopausal women, 84% had
natural menopause and 16% had surgical menopause. The
median age of natural menopause was 50. The median age of
surgical menopause was 44. Among women who had never used
HRT, the risk of breast cancer was lower m postmenopausal
women than premenopausal women, but the relative risk
increased with increasing age at menopause. Breast cancer
risk was similar among those with natural menopause (2.9%)
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and surgical menopause (2.4%). Women who had experienced
menopause 1 to 4 years prior to the diagnosis of breast
cancer had a lower risk than premenopausal women. The risk
of breast cancer among postmenopausal women decreased 2.7%
each year after menopause. The trend was similar in
relation to surgical versus natural menopause. Thus, in
this analysis, the risk of breast cancer for those women
who had never used HRT is related to menopausal status and
the time of menopause, whether it was natural or
surgically induced.
Of the women who had a diagnosis of breast cancer,
34% had used HRT at some time. The median age at diagnosis
of breast cancer was 59. In all the combined studies a
risk of breast cancer was noted with the use of HRT. Time
duration of use ranged from less than one year (26%) to 10
years or longer (15%). The length of time utilized
corresponded with a greater risk. In contrast, for women
who had stopped using HRT for 5 years, the risk decreased
(Collaborative Group on Hormonal Factors in Breast Cancer,
1997) .
in summary, the Collaborative Group on Hormonal
Factors in Breast Cancer (1997) found that the risk of
breast cancer was higher in women who had used HRT as
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compared to those who had not. The risk increased with a
longer duration of usage but was reduced when HRT was
stopped. Postmenopausal women had a lower risk of breast
cancer than premenopausal women. There was strong evidence
to suggest a link between the time of menopause and breast
cancer diagnosis. Women who used HRT were more likely to
have their breasts examined than those who did not take
HRT; therefore, cancer may have been detected earlier
among those women. This study was germane to the current
research in that a risk of breast cancer is one of the
reasons women express as a reason for not taking HR± .
Johannes, Crawford, Posner, and McKinlay (1994)
sought to investigate the use of HRT in middle-aged women,
noting that estrogen and progestin therapy had been
increasing since the 1980s. Trends had been influenced
related to the risk of endometrial and breast cancer and
the benefits associated with cardiovascular disease and
osteoporosis. The researchers had three objectives. The
first was to calculate the prevalence and incidence of HRT
utilization related to menopausal status. The second
objective was to determine patterns of HRT utilization
_i Qfatus and the final objective was
related to menopausal status,
-i n-i tiatincr or discontinuing HRT.
to examine reasons for initiating
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Menopausal status was identified in three categories.
Naturally menopausal women were those who had experienced
at least 12 months of amenorrhea. Surgically menopausal
women were those who had experienced cessation of menses
by removal of the uterus or ovaries. Those women who had
menses in the last 12 months, but not in the last 3
months, or had cycle irregularity were classified as
perimenopausal, and women who had periods in the 3 months
prior to the study were premenopausal. HRT was defined as
hormonal pill use for menopausal or aging symptoms.
Johannes et al. (1994) used a longitudinal cohort
method. Convenience sampling was used to recruit 2,424
women ages 45 to 55 in an eastern state. Six telephone
interviews were conducted 9 months apart from 1981 to
1987. Descriptive analyses were used to compare trends.
Univariate comparisons were used when a woman initiated
HRT during the study. Proportions were compared in two
groups by chi-square analysis. Logistic regression models
examined factors related to a change m HRT.
Use or nonuse of HRT was analyzed on 2,224 of the
4-v,^ at-udv Two hundred seventy-four (12.3%)
2,425 women m the stuay.

reported using HRT, whereas 1,950 (87.7%) did not use HRT
during the study. Prevalence o£ HRT was higher among those
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with surgical menopause than with natural menopause. An
increase in the combination of estrogen and progestin was
seen over the course of the study. Prevalence was low in
premenopausal women. An increase from 33.3% to 52.4% was
seen in women who just had surgery and declined with older
surgical menopause from 21.4% to 6.9%. Continual patterns
of use was seen in surgically menopausal women (62%). Hot
flashes were related to initiation of HRT among those with
natural menopause. Sixty-two percent of the reasoning for
initiating HRT was hot flashes. Only 3.7-5 began therapy
for prevention of osteoporosis. The most common reason for
stopping therapy was related to bleeding (Johannes et al. ,
1994) .
in summary, Johannes et al. (1994) found that overall
use of HRT was 12.3%. Women who had surgical menopause
were more likely to use HRT than those with natural
menopause. Those women who had surgical menopause were
likely to initiate therapy quickly or not at all.
Surgically menopausal women tended to take unopposed
estrogen (84%). Speakrng with a health care provider and
symptoms of menopause were the determining factors in
initiating HRT in natural occurring menopause.
Discontinuation of HRT also was related to contact with a
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health care provider. HRT in perimenopausal women is
important for long-term prevention of cardiovascular
disease and osteoporosis. The Johannes et al. (1994) study
was germane to the current research in that HRT was found
to be used in only a small percentage of women and not for
the long-term benefits. Use of HRT was further
investigated by the current researcher and the large meta
analysis provided rich grounds for comparison findings.
In summary, many studies have been conducted on the
risk and benefits of HRT. Studies have shown that women
have optimistic or impartial reactions to the event of
menopause (Daly et al . , 1993). Increase in quality of life
has been found in the use of HRT (Limouzin-Lamothe et al. ,
1994). Women use HRT in relation to symptoms and long-term
benefits (Newton et al., 1997). But overall only 12.3% of
the women in a study consisting of over 2,000 women used
HRT (Johannes et al. , 1994). The aim at increasing the
long-term effects of HRT depends on education and
communication. Further research is needed to evaluate all
sections of the United States on the utilization of HRT.

Chapter III
The Method
Over 40 million women in the United States have
experienced menopause (Scharbo-Dehaan, 1996). Only 20% of
those postmenopausal women are using hormone replacement
therapy (Cumming & Cumming, 1998a). Women experiencing
menopause may experience health problems and symptoms
related to menopause. These symptoms and health problems
may be alleviated by the use of human replacement therapy
(HRT) (Howell & Brodman-Grimm, 1999). Therefore, the focus
of this study was to determine the use of HRT m rural
southern menopausal women. In this chapter, the method,
sample, and data analysis used in this study will be
described.

Design cf the Study
The design of the study was a cross-sectional,
descriptive study. Polit and Hungler (1999) have defined
cross-sectional design as a research design in which data
are collected at one point in time.
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Sett ing, Populatioru and Samp!e
The setting was a church and a beauty shop in rural
northeast Mississippi. The pastor and the beauty shop
owner agreed to allow women who visited these places to
participate in the study. The population of this rural
southern community was approximately 900 people. The main
industry was manufacturing. The church members and patrons
of the beauty shop were mostly rural Caucasians. There
were approximately 150 active members of the church, and
of those 150 members approximately 50 were women with 20
of those being 45 years old or older. The beauty shop is
open 6 days a week. Approximately 200 customers visit the
beauty shop regularly, averaging 15 patrons daily. One
half of those 200 customers were women with 50% of them
being 45 years or older. This made the accessible
population for the study equal to approximately 120.
Rural southern women ages 45 and older were the
target population for this study. The actual body
consisted of premenopausal and postmenopausal women.
^ nnnQPTit forms to participate in
Fifty-five women signed consent
r-nhshi litv convenience sampling method
the study. A nonprobabiilty
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was utilized related to the availability of the subjects
and convenience.

Method ofhData.
Instrumentation. The Campbell Hormone Replacement
Questionnaire, a 16-item researcher-designed instrument,
was used for data collection (see Appendix A) . The
demographic section of the Campbell Hormone Replacement
Questionnaire included four questions pertaining to age,
race, education, and method of payment for health care.
Questions 5 through 16 were related to menopause,
menopausal symptoms, and the use of hormone replacement
therapy (HRT) . Questions 3, 4, 8, 11, 12, 14, and 15
allowed the participant to mark all answers that applied.
All questions excluding question 16 were answered by
marking the appropriate box. Question 16 allowed the
participant to add to any additional comments related to
HRT. Total time for completion of the questionnaire was
approximately 10 minutes.
The Campbell Hormone Replacement Questionnaire was
•1
pvnerts in order to test its
reviewed by a panel or
P
readability and face validity. Revisions were made based
on the comments and concerns of the panel.
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Data Collection Procedurp
Permission was obtained to conduct the study from
Mississippi University for Women's Committee on Use of
Human Subjects in Experimentation (see Appendix B).
Written permission was obtained from the pastor of the
church and the owner of the beauty shop (see Appendix C).
Individuals in the women's classes at the church were
asked to participate in the study pertaining to HRT. The
Campbell Hormone Replacement Questionnaire and the consent
form (see Appendix D) , enclosed in an envelope, were given
to women ages 45 and older in the classes by the
researcher. Twenty women agreed to participate m the
study. The classes were instructed that confidentiality
would be maintained by the researcher by separation of the
signed consent form from the questionnaire after
completion. The researcher would, therefore, not know who
had filled out the questionnaire. After signing the
consent form, the researcher retrieved the forms from the
participants and placed them in an envelope, when
completed, the participants inserted the questionnaire
into their original envelope. After having sealed the
envelope, the participant then handed it to the
researcher.
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The consent forms and questionnaires were left at the
beauty shop for 2 weeks. The researcher instructed the
owner of the shop regarding how to distribute the
questionnaire to those women 45 years old and greater who
agreed to participate in the study. The researcher
informed the shop owner that a questionnaire and a consent
form would be in a packet. The packet would be given to
each woman 45 years and older. If the woman agreed to
participate in the study, she was to sign the consent form
and hand it back to the shop owner, who was to place all
the consent forms in an envelope. After completion of the
questionnaire, the participant was to insert the
questionnaire into the initial envelope, seal it, and hand
the envelope back to the shop owner who would then give
all the answered questionnaires and the signed consent
forms to the researcher. The shop owner was not to look at
or discuss the questionnaire. Confidentiality would be
nne knowing who fillsd out the
maintained with no one K.II
^

questionnaire. Thirty-five women participated in the
study. The beauty shop owner followed the directions given
,
hhprefore, confidentiality was
by the researcher; theretore,
maintained.
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Method of Data Analysis
Descriptive statistics were used to describe and
synthesize the data. Descriptive statistics were used to
describe sample characteristics and to describe
information about the variables (Polit & Hungler, 1999).
Frequencies and percentages were calculated to provide a
description of the sample.

Summary
The goal of this research study was to elicit
information regarding the use of HRT in menopausal women.
Rural southern menopausal women were the target
population. The instrument consisted of demographics and
menopausal and HRT data. The methodology was described
including procedure for consent and maintaining
confidentiality of the participants. Descriptive
statistics comprised the data analysis.

Chapter IV
The Findings
The purpose of this study was to assess the use of
hormone replacement therapy (HRT) in southern rural
menopausal women. A descriptive design was employed to
examine the variables. Parse's (1995) Human Becoming
Theory was used as the theoretical framework. Data were
collected using the Campbell Hormone Replacement
Questionnaire. Descriptive statistics were used for data
analysis. In this chapter, the sample is described and
data analysis is presented.
D.escript ion of—Sample
The study population included women who met the
following criteria: (a) at least 45 years of age, (b) pre-

or postmenopausal, (c) lived in a rural community in
-rarq frP visited the church or
northeast Mississippi, and (d) visicea
wpre

beauty shop where data w

collected. Data were collected

M
1 4 2000 and May 27, 2000. Fifty-five women
between May 14, 2uuu,
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completed the questionnaire and all met the criteria to be
included in the study. All subjects were Caucasian.
The age of respondents ranged from 45 to 84 years,
with a mean age of 58.15 years (SD = 10.22), indicating a
large variation in the ages of the subjects. Distribution
of sample by age can be found in Table 1.
Table 1
Demographic Ages .ojf_-Momen -Respondents Expressed in
Frequency and Percentage

fa

Ages (years)
45 to 54

23

41.8

55 to 64

16

29.1

12

21.8

4

7. 3

65 to 74

aN

%

= 55.
Education ranged from 20% having completed grade

school, 49.1%

i

completed

hi ah school, while 21.8% had some
high scno

college credits and 9.1% having completed college. Of the
respondents, 32.7% indicated they paid for therr health
care by Medicare. A total of 3.6% use Medicard, and 80%
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had private insurance. A total of 12.7% paid cash for
their health care, and 1.8% of the respondents were unable
to pay. A total of 7.3% used a combination of private
insurance and cash, while 20% used a combination of
Medicare and private insurance. A total of 3.6% of the
respondents used a combination of Medicare and Medicaid.
Results of Data Analysis
Xn regard to menopausal status, 70.9% of the women
had experienced menopause with 41.8% having occurred
naturally and 43.6% surgically. A total of 14.5% of the
women were experiencing menopausal with 10.9% having not
gone through menopause. A total of 62.5% of the women had
their ovaries and uterus removed with 33.3% having only
the uterus removed. A total of 4.2% of the respondents did
not know what type of hysterectomy they had.
Menopausal symptoms varied with the respondents.
Distribution of the symptoms can be found in Table 2.
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Table 2
Menopausal,
Expressed in Frequency and

Menopausal symptoms

Hot flashes

32

58 . 2

Night sweats

21

38.2

Vaginal itching

7

12.7

Vaginal dryness

18

32.7

8

14.5

Sex drive changes

17

30 .9

Sleep disturbances

17

30.9

8

14 . 5

21

38 . 2

11

20.0

Skin changes

Urinary incontinence
Mood swings
No symptoms

aN

= 55.
It should be noted that all women responded to this

uestion regarding menopausal symptoms regardless of
'hether they had experienced menopause or not. Twelve
joint five percent of the non-menopausal respondents
ixperienced sex drive changes. Also 12.5% of these women
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reported sleep disturbances, and 27.7% reported mood
swings.
Three questions guided this study. The first question
was what is the prevalence of HRT in rural southern
menopausal women? Distribution of HRT use can be found in
Table 3.
Table 3
The Use
Hm-rmrvnR Replacement Therapy of Women
Respondents.-

HRT use

an

Yes, use HRT

27

57.4

No, do not use HRT

20

42 .6

= 47.
The second question was what reasons do rural

for- usinq HRT? Distribution
southern menopausal women cite for using
for- use can be found in Table 4.
of reasons for
use can
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Table 4
Respondents Expressed in Frequency and Percentage

o,
"o

Reason for taking HRT

fa

Health care provider told them to

24

96 .0

I know it is good for me

8

32 .0

I asked HCP to prescribe it to me

2

8.0

3n

= 25.
The third question guiding the study was what reasons

do rural southern menopausal women cite for not using HRT?
See Table 5 for distribution of reasons for nonuse.

Table 5
Reasons

Respondents-ExpresafidUn

Jhera^l^

-andJeroentage

-J-requsncy

Reason for not using HRT

Has not been discussed with me
Don't know enough about it
Don't think I need it
an

= 18.

1

5 .9

5

29.4

2

00

Scared of side effects

10

58.8
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Additional Findings
Of the 28 women currently not taking HRT, 32.1%
indicated that they had taken it in the past and had
stopped. Reasons cited for stopping the HRT can be found
in Table 6.
Table 6
Respondents Expressed in Frequency and Percentage

Reason for stopping HRT
Side effects
Not doing me any good
Health care provider told me to
Withdrawal bleeding
Scared of breast cancer
an

1

10.0

5

50.0

3

30.0

1

10.0

1

10.0

= 11.
One hundred percent of the women taking HRT indicated

they were taking it orally. Of the 55 women in the sample,
• j- ,-ori t-heir mother was taking HRT. Ten
11 (20%) indicated
their muu
^
sister was taking it while one (1.8%)
(18.2%) stated their sis
, •
upt Twenty (40%) of the women did
had a daughter taking HRT. Twenty
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not have family members using HRT, and 6 (10.9%) did not
know if family members were using HRT. Additional comments
made by the women varied. One woman stated that she had
problems if the pills were not taken. Another lady stated
she would lose her mind without them. One of the ladies
who had stopped taking HRT and started back stated she did
so due to the symptoms of menopause, such as hot flashes,
vaginal dryness, and sex drive changes, started to occur.
Several of the women commented they knew that HRT helped
with bones, skin, hair, and heart disease.
Summary
In this chapter the sample of respondents who
volunteered to participate in the study was described. The
purpose of the study was to determine the use of HRT in
rural southern menopausal women. The Campbell Hormone
Replacement Therapy Questionnaire was utilized for data
collection. Responses provided data that answered the
-i mn fhp use of HRT and the
research questions regarding
reasons for use or nonuse.

Chapter V
The Outcomes
The purpose of this study was to determine the use of
hormone replacement therapy (HRT) and reasons for its use
or nonuse in rural southern menopausal women. Summary and
discussion of the findings, conclusions, implications for
nursing, and recommendations for future research are
presented in this chapter.
Summary of Findings

Fifty-five Caucasian women ages 45 and older
comprised the convenience sample for thrs study. The mean
age of the respondents was 58.2 years (SD - 10.2 years).
The minrmum age was 45 years, and the maximum age was 84
years. The median age was 57 years.
Almost half, or 49%, of the respondents had at least

a high school education while 20% had only completed grade
school. Another 21.8% indicated they had completed some
college, while 9.1% were college graduates.
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The vast majority of the women (80%) paid for their
health care by private insurance wile 32.7% had Medicare
and 3.6% used Medicaid. Health care was paid for with cash
by 12.7% of the women, and 1.8% indicated they were unable
to pay for their health care. A combination of private
insurance and cash was used by 7.3% while 20% had a
combination of Medicare and private insurance and 3.6% had
a combination of Medicare and Medicaid.
Of the total sample (N = 55), 70.9% had experienced
menopause, 14.5% were currently going through menopause,
and 10.9% indicated they had not yet experienced symptoms
of menopause. The reported cause of menopause was almost
evenly divided with 48.9% having experienced menopause
naturally and 51.1% having had menopause due to surgery.
Of the 24 women who indicated that their menopause was due
to surgery, 33.3% reported only their uterus was removed
o t a
uforus and ovaries removed, and 4.2%
while 62.5% had both uterus diw
were unsure.
,,B 9c.\ ied the symptoms the women
Hot flashes (58.2«)
lea un
7
experienced. Mood swings were identified by 38.2%. Night
sweats were experienced by 38.2% of the respondents.

Vaginal itching was

n -i

reported

y

-i o 7^

and 32.7% hsd

Skin changes were indicated by 14.5% of
vaginal dryness. Skin cna y
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the respondents, and 30.9% had experienced sex drive
changes. Sleep disturbances were reported by 30.9% of the
55 respondents, while urinary incontinence was reported by
14.5%. No menopausal symptoms were reported by 20% of the
sample.
Of the total sample, 49.1% indicated they were
currently taking HRT. This percentage included 27 of the
47 (57.4%) menopausal women. Fifty point one percent of
the respondents reported they were not using HRT,
including 20 of the 47 (42.6%) menopausal women.
Of the 28 respondents not using HRT, 32.1% indicated
they had used the therapy in the past and had stopped, and
67.9% had never used HRT. Of the 10 respondents who
indicated they had stopped taking HRT, 10% stopped due to
the side effects, 50% stopped because they did not believe
it was doing them any good, and 30% discontinued use
-14-v.
nrovider recommended stopping,
because their health care proviaex
Withdrawal bleeding was

v^nnrt-pd as a reason for stopping
P

i
while another 10% stopped
HRT by 10% of the respondents, while a
due to fear of breast cancer.
Women who had never used HRT were not using it
V,
Uh rare providers had not discussed it
because their health car p
^
were not using HRT because
with them (29.4%), and 58.8s were

they did not think they needed it. Fear of side effects
was a reason for nonuse for 5.9% of the respondents, while
11.8% indicated they did not know enough about HRT to risk
initiating it.
One hundred percent of those taking HRT were taking
the pill forms of the therapy. Of the 25 respondents who
were taking HRT, 96% were doing so because their health
care provider suggested it, and 32% took it because they
thought it was good for them. Of the respondents taking
HRT, 8% had asked their health care provider to prescribe
it for them.
Forty percent of the respondents did not have family
members taking HRT, while 20% indicated their mothers used
HRT. Other family members of the respondents who used HRT
were daughters (1.8%) and sisters (18.2%). Several women
(10.9%) did not know if any family members used HRT.

Additional comments made by the respondents were that
•
t hea^t disease and helps with skin and
HRT protects against hea^u
_
.
that her surgeon suggested
hair. One respondent indicat
HRT for her bones, heart, and energy. Others indicated
they used HRT for symptoms of menopause,
. , drvness, sex drive changes, and mood
flashes, vaginal dryness,
swings.
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Discussion
Findings from the current study indicated that HRT
increased quality of life by decreasing menopausal
symptoms. These findings are supported by Daly et al.
(1993) who found that a great number of women experienced
improved quality of life from the utilization of HRT.
Women felt that quality of life was diminished by the
beginning of menopausal symptoms. The findings by
Limouzin-Lamothe et al . (1994) indicated that menopause
affects a woman's life in varying degrees and methods such
as HRT are suggested to diminish menopausal symptoms.
Wiklund et al . (1993) found that the utilization of HRT
had the potential to nullify menopausal symptoms that
decreased women's quality o£ life. Women may believe that
menopause decreases the quality of life but that the use
of HRT diminishes the symptoms of menopause, therefore,
increasing quality of life.
Findings from this study supported the conclusions of
Newton et al. (1997) that women chose not to take HRT
-V, rrht they did not need it or that HRT was
because they thought
Y
al (1997) further
not doing them any good. Newton et al.
;luded
conc.

that

reason women

,7qirian recommendation

physician re.

was the primary

initiated HRT. Finally, Newton et al. (1997)
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found that women stopped taking hormones on their own or
with the advice of a physician. In the current study 58.8%
of the women reported they did not take HRT because they
did not think they needed it . Other respondents indicated
they stopped using HRT because the medication was not
doing them any good (50%) or their physician took them off
of HRT (30%) . Ten percent feared the development of breast
cancer from using HRT. The reason most commonly cited in
the current research for using HRT was because the health
care provider told them to (96%). Women may assume that
HRT is not doing them any good because they cannot see the
effects of HRT on osteoporosis. Women may believe that HRT
does not lessen the risk of heart disease because they
physically see this benefit. Some women may not see
menopause as a negative aspect o£ life and therefore do
not think they need HRT because they do not experrence
negative menopause! symptoms or believe these s^ptoms to
be a natural part of growing ol
The findings in the current study also were supported
by a study conducted by Salamone et al. (1996) that
0,.nns

revealed the primary n

for initiating estrogen

^ ^ to hysterectomy, menopausal symptoms,
therapy were due to y
+• • on and prevention of osteoporosis,
physician recommenda 1
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Reasons given by the women for discontinuing estrogen
therapy were not thinking they needed it, not
understanding the side effects, or believing the therapy
might be harmful. Because women cannot see the positive
results of HRT, such as decreasing the risk of heart
disease and osteoporosis, they may assume the therapy is
not needed. Nurse practitioners should stress the positive
effects of HRT regardless of whether such effects can be
physically visualized or quickly manifested.
The risk of breast cancer is one of the reasons women
expressed as a reason for not taking HRT in this study. In
the current research 10% of those women who stopped taking
HRT did so due to being soared of breast cancer. The
Collaborative Group on Hormonal Factors in Breast Cancer
(1997) found that the risk of breast cancer is higher in
women who have used HRT compared to those who have not.
Pear is a strong motivator in preventing the use of HRT.
Education by the nurse practitioner regarding the risk
npm mav alleviate these fears,
benefit ratio of using HRi may ai
_ made by the respondents reported
Additional comments maae uy

rh-F the symptoms of menopause, such
they took HRT because of th
Y™
as hot flashes,

i Hrvness,
vaginal
y

sex drive changes, and

v^-r one symptom reported by the
mood swings. The numb
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respondents related to menopause was hot flashes (58.2%)
followed by mood swings (38.2%). The reason most commonly
cited for stopping HRT was the belief that the therapy had
no benefits (50%) followed by health care providers
recommending that they stop (30%). These findings were
similar to those in a study conducted by Johannes et al.
(1994) who found that speaking with a health care provider
and symptoms of menopause were major determining factors
for taking HRT. Likewise, discontinuation of therapy was
related to discussions with their health care providers.
The earlier researchers also noted that hot flashes were
one of the number one symptoms reported related to
menopause. Menopausal symptoms interfere with activities
of daily living. These symptoms can also have an impact on
personal relationships and intimacy. HRT may diminish
these symptoms and place the woman in control of the
situation. However, lack of knowledge and encouragement
about taking HRT on the part of health care providers
=, threat to quality of life in menopausal
apparently poses a thre
women.
UPT has been shown to improve the
In summary, HRT has oee,
f QphLarbo - Dehaan, 1996) .
negative effects of menopause (Scharb

Major health problems can re

.] t~ from a decrease in
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estrogen, but HRT can reduce the incidence of these
complications (Smith & Hughes, 1998). Yet side effects,
physician advice, fear of cancer, and lack of education
often prompt women to discontinue the use of HRT (Newton
et al., 1997). The current research supported previous
studies about the reasons for the use and nonuse of HRT.
Menopausal symptoms affect the quality of life of women in
various ways and degrees. Many health problems can occur
related to menopause. Not all these health threats can be
perceived by the woman. The use of HRT can help alleviate
the negative effects of menopause and diminish the risk of
complications that can develop when a woman experiences
menopause.
Conclusions
This researcher explored the use of HRT in a small
rural community. The researcher concluded that hot
1 Hr\/"nPS S

flashes, mood swings, vaginal drynes ,

S6X drive chencjes ,

the symptoms that most
and sleep disturbances were th
y^P
women Only about half the
concerned these menopausal women.
ur,T qome of the women who
women rn the study were using HRT. Some
were initially taking

udT

had

stopped, believing the

medication was doing them no g

The results of the
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findings accentuated the need for more education on the
benefits of HRT, as the women who were not using HRT
failed to do so because they did not think they needed it.
Health care providers were instrumental in initiating the
therapy but were not utilizing HRT in the pill form, among
this sample as all of the respondents were using the oral
form. The prescription should be individualized with the
client being aware of all types available. Health care
providers, such as nurse practitioners, can motivate and
educate women on the benefits of HRT related to decreasing
symptoms of menopause and lessen the ^ompj-icat ions
associated with a decrease in estrogen that is experienced
by menopause.
Implications for JSInrsing
Practice. Findings from this study underscore the
importance of educational programs regarding risk factors
associated with osteoporosis and heart disease. Nursing
at- all levels must address the need to
education programs at al
n r,c ranae health benefits to their
utilize HRT for the long rang
_
<c
nurse practitioner include
clients. The roles of a nurse p
1-pacher and researcher. These roles
counselor, advisor, teacher,
an helping individualize management
are essential to women m helpi g
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of menopause and the use of HRT. Nurse practitioners
working with rural southern women need to understand the
culture and beliefs of these women, particularly
concerning the perception that discomforts and quality-oflife changes associated with menopause are inevitable.
Research^ No research was found on the use of HRT in
rural southern women. Nurse practitioners in these rural
areas need further studies to guide them in educating and
understanding the norms and beliefs in the region in which
they serve. Research is often conflicting, especially
concerning this matter and should include southern women
and their beliefs about the risks and benefits of using
HRT. Findings from the current research expand knowledge
of the use or nonuse of HRT and can be utilized as a
starting place £rom which to create empirically based
n
*
rh improve
*i morove the health status and
interventions designed
to
quality of life of menopausal women.

Theory,. Parse's Human Becoming Theory describes the
rantains of their health. As
human beings as being the captai
seen in
are

this current research and previous studies, women

taking their health into their own hands by not using

or stopping the use of HRT or to a lesser degree, by
asking health care providers to prescribe HRT. Nurse
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practitioners should guide these women to change and see
the familiar in a different light by educating them. With
solid and accurate information, women can make an educated
decision related to their health care regarding HRT use.
Education. What is learned from research is used in
primary care and in nursing education. Educational
programs in the community can provide opportunities for
women to learn about menopause and HRT. Counseling and
individualized care can lessen fears and give women
opportunities to relate their experiences of menopause and
their concerns related to the use of HRT. Findings from
this study may also be incorporated into curricula in
graduate programs of nursing to heighten the awareness of
prospective health care providers and educators about the
issues surrounding use and nonuse of HRT in the rural
South.

Recommendations._£omJhitiire...Eesearch
The following recommendations were based on findings
of this Study:
of i-he study with a larger sample,
1. Replication of the scuuy

mcluding various cultures

and ethnic backgrounds.
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2. Conduction of a qualitative study exploring
women's reasons for use or nonuse of HRT.
3. Conduction of further studies refining the
Campbell Hormone Replacement Questionnaire pertaining to
menopausal symptoms, reasons for use of HRT, and for not
using HRT.
4. Conduction of a study exploring health care
providers' reasons for failing to prescribe or discontinue
HRT in healthy perimenopausal women.
5. Implementation of an education program about HRT
in rural cities.
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Campbell Hormone Replacement
Therapy Questionnaire
Thank you for agreeing to participate in my study. All
answers are confidential Please do not place your name on
the survey. Mark an "X" or write in an answer in the blank
spaces. Please answer all questions.
1.

Age:

2.

Race
Q a.
• b.
•c.
• d.
• e.

3.

years

White
Black
Asian
Spanish
Other. Please specify:-

Last grade completed in school (check only one)
• a.
•b.
• c.
•d.

4.

-

Grade school
High school
Completed some college courses
Graduated from college

How do you pay for your health care? (Check all that
apply)
• a. Medicare
• b. Medicaid
Q c. Private insurance
•d. Cash
•e. Charge
• f. Unable to pay

^1
5.

mDnnnause

(12 months without
through menopause?

Have you
periods) or are go-my
• a Experienced menopause
•b. Going through menopause
• c. Neither
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If you have experienced menopause, was it
Q a. Natural: The gradual decreasing of estrogen,
resulting in the cessation of ovulation and
thus menstruation.
Q b. Surgical: The surgical removal of the uterus
and or the surgical removal of the ovaries
resulting in the abrupt end of menstruation.
If menopause was due to surgery, what was removed?
• a. Ovaries
• b. Uterus
• c. Ovaries and uterus
• d. Don't know
Which of the following menopausal symptoms do you
experience? (Mark all that apply)
• a. Hot flashes
• b. Night sweats
•c. Vaginal itching or burning
Q d. Vaginal dryness
• e. Skin changes
• f. Sex drive changes
• g. Sleep disturbances
•h. Urinary incontinence
• i. Mood swings
•j . Not having menopausal symptoms
Q k. Other. Please specify-—
Do you currently take hormone replacement therapy?
•a. Yes
• b. No
do not currently -ke^ormon-eplacement

I£ YOU

•T^TstoPPed taking hormone replacement
•b. NotThave never taken hormone replacement
+-

ln^r-^r)V .
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11-

12.

If you stopped taking hormone replacement therapy,
why did you stop? (Mark all that apply.)
• a. The side effects
Q b. Too expensive
Q c. Didn't think it was doing me any good
• d. My health care provider took me off it.
•e. Withdrawal bleeding
Q f . Scared of breast cancer
•g. Scared of endometrial cancer
•h. Other. Please specify:
If

you are not taking hormone replacement therapy and
have never taken it, what is your reason? (Mark all

that apply.
O a. I'm scared of the side effects.

13

• b.

My health care provider has not discussed it

•c.

with me.
I don't know enough about it.

• d.

I don't think

• e.

Other. Please specify:_

I

need it.

If you are currently using hormone replacement
therapy, what kind do you use?
• a. Oral (pills)

14

• b.

Patches

•c.

Creams

•d.

Injections

• e.

Other. Please specify:-

I£

you take hormone replacement therapy, what is your

reason9 (Mark all that apply)

•a

My health care provider told me to

•b

I know it is good for me to take it.

•c'. I asked my health care provider to prescrrbe rt
•d.
• e.

someone other than my health care provrder told
Theardlbout't

on the t.v., newspaper, or

radio.
•f.

•

Don't know

Other. Please specify:
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What members of your family take hormone replacement
therapy? (Mark all that apply)
Q a. Mother
b. Sister
Q C. Daughter
—] d. Grandmother
• e. None
Q f. Don't know
Please make any additional comments about hormone
replacement therapy that you would like to in the
space provided.
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MISSISSIPPI
UNIVERSITY
W OMEN

Office of (he Vice President tv»r Academic Allaim
i udora Wells Hall
W-Bo\ 16<m
Columbus. MS 7g?() I

Ib62) 72^-7 142

for

(662) 72d-7 141 1 ax

Admitting Urn Stmt IVX2

Apr l1 2 6, 2000

Ms. Angela J. Campbell
P. O. Box W-910
Campus
Dear Ms. Campbell:
[ am pleased to inform you that the members of the Committee
on HuLnsubj.ee in Experimentation have approved your proposed
research with she
confidentiality of the qu
the beauty shop
responsible for its mcegu y
,.t« be

co-itt.e objected to
Questionnaire and being
co^ttSe suggested that one of
, rr
i tv • (1) You could
t-s to P«"

you could PJ£P»£/«£» ^.ted^cS"
bWP"ncdludeC

Cself-addressed,

"h
7
steeped
envelope
questionnaires can be sent directly b»oX to you.
I wish you much success in your research.

Sincerely,
;&o^ V. a(SahA s
Sheila V. Adams, Ed.D.
Interim Vice President

for Academic Affairs

SA: wi
cc :

Mr. Jim Davidson
Dr. Melinda Rush

Where

Excellence

is

a Tradition

so

the
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PERMISSION TO CONDUCT STUDY
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1602 CR 86
New Albany, MS 38652

Reverend John Stewart
Friendship Baptist Church
107 Friendship road
Ecru, MS 38841
Dear Reverend Stewart,
My name is Angela Campbell. I am a registered nurse and
graduate student at Mississippi University for Women m
Columbus, Mississippi. I am conducting a research study
concerning the use of hormone replacement therapy by rural
southern women. I am requesting permission to conduct t is
study at your church.
The subjects will be women ages 45 and older who wish to
participate. Each participant will have the opportunity to
refuse participation, and confidentiality will be
refuse pa
y 1 •
ts win answer a questionnaire
maintained. Pa
P
Questions related to menopause
including demographics;questiO
^^ ^^
and hormone replacement tnerapy
questionnaire.
nprmission

^u^^onf

to conduct this study

- — —»

sending me a permission letter.
• _ p. 2 vi gp *1 ti r his ma11er .
I appreciate your assistance m
Sincerely,

Angela Campbell
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FRIENDSHIP BAPTIST CHURCH
107 Friendship L.oop
Ecru, Ms. 3884 i
"And the one who comes to me I will ceriumly not oust out
John 6:37
John W. Stewart, I) Mm.
Faster

May 15,

2000

Ms. Angela Campbell
1602 CR 8 6
New A l b a n y , MS
38652
Dear Ms. Campbell:
This i s to verify that you have permission to conduct

I s U d y a b o u t hormone replacement therapy a t our church
Wishing you the best in your nursing career.
In Christ ,
John Stewart
bs

.
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1602 CR 86
New Albany, MS 38652

Nell's New Styles
ATTENTION: Nell Tutor
6777 Highway 15
Ecru, MS 38841
Dear Mrs. Tutor,
My name is Angela Campbell. I am a registered nurse and
graduate student at Mississippi University for Women m
Columbus, Mississippi. I am conducting a research study
concerning the use of hormone replacement therapy by rural
southern women. I am requesting permission to conduct this
study at your beauty shop.
The subjects will be women ages 45 and older who wish to
participate. Each participant will have the opportunity to
refuse participation, and confidentia I y wi
maintained Participants will answer a questionnaire
maintained, ru
^
questions related to menopause
including
»o namee will be on the
and hormone replacement tnerapy
questionnaire.
r~,ir-

nprmission to conduct this study
abou^hormone replacement therapy at your beauty shop by
sending me a permission letter.
-i
T""*
i n. thls ma11a ic •
I appreciate your assistance m
Sincerely,

Angela Campbell
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Dear Participant,
My name is Angela Campbell. I am a registered nurse
enrolled in a master's degree nursing program at
Mississippi University for Women in Columbus, Mississippi.
I am conducting a research study concerning the use or
nonuse of hormone replacement therapy by rural southern
women. I am requesting your participation in this study as
findings of this study will provide health care providers
information of the utilization of hormone replacement
therapy in rural southern women. Your participation will
require approximately 15 minutes of your time to complete
the questionnaire.
Completion of the questionnaire and your signature on this
form will indicate your agreement to participate m this
study. Participation is voluntary, and your
confidentiality will be maintained as the consent forms
and the questionnaire will be placed in an envelope as
soon as they are completed and will be viewed only by
myself The questionnaire will not include the names of
the participants. You may withdraw from the study any time
the questionnaire is handed in. The information
given will be used only in this study.
b e f o r e

Sincerely,

Angela Campbell, RNC, BSN

to oarticipate in Angela Campbell's research
I agree to paruicip
study.
Signature of Participant

Date

